AACD/AD subjects presented elevated t-tau and p-tau181 concentrations in respective areas of the brain. Study supports the elevated distribution of tau and p-tau in respective area of the brain for AACD and Alzheimer disease patients (p < 0.001). This evidence concerns the gene MAPT and Alzheimer disease.